...
首页> 外文期刊>American journal of psychiatry >Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5.
【24h】

Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5.

机译:神经科学,临床证据以及DSM-5中精神病学分类的未来。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the initial stages of development of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), we expected that some of the limitations of the current psychiatric diagnostic criteria and taxonomy would be mitigated by the integration of validators derived from scientific advances in the last few decades. Throughout the last 25 years of psychiatric research, findings from genetics, neuroimaging, cognitive science, and pathophysiology have yielded important insights into diagnosis and treatment approaches for some debilitating mental disorders, including depression, schizophrenia, and bipolar disorder.
机译:在第五版《精神疾病诊断和统计手册》(DSM-5)的最初开发阶段,我们希望通过整合来自以下人员的验证器,可以减轻当前精神病学诊断标准和分类法的某些局限性近几十年来的科学进步。在过去的25年的精神病学研究中,遗传学,神经影像学,认知科学和病理生理学的发现已为某些令人衰弱的精神障碍(包括抑郁症,精神分裂症和躁郁症)的诊断和治疗方法提供了重要见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号